EUROTROPIN SOMATROPINE 45IU (15MG)

Professional Pharmaceutical Product Description

PRODUCT NAME & PACKAGING

Brand Name: Eurotropin Somatropine
Generic Name: Somatropin / Recombinant Human Growth Hormone (r-hGH)
Strength: 45IU / 15mg
Dosage Form: Injectable somatropin preparation for subcutaneous administration
Packaging: 45IU (15mg) presentation; use only with the manufacturer-approved diluent, device, and administration instructions where applicable.

PRODUCT OVERVIEW

Eurotropin Somatropine contains somatropin, a recombinant form of human growth hormone designed to supplement or replace naturally occurring growth hormone in patients with confirmed medical need. Somatropin supports growth-related and metabolic processes by acting through growth hormone receptors and by promoting downstream insulin-like growth factor-1 (IGF-1) activity.

This product is intended for prescription use only and should be administered under the supervision of a qualified healthcare professional experienced in growth hormone therapy.

INDICATIONS

Somatropin may be used in medically diagnosed conditions where growth hormone replacement or growth support is clinically appropriate, including:

Pediatric Use
• Growth failure due to inadequate endogenous growth hormone secretion
• Short stature associated with selected genetic or growth-related conditions, where approved
• Children born small for gestational age who fail to show adequate catch-up growth, where clinically indicated
• Other approved pediatric growth disorders depending on local prescribing information

Adult Use
• Replacement therapy in adults with confirmed growth hormone deficiency

Use should be based on clinical diagnosis, laboratory assessment, patient history, and applicable local regulatory approvals.

DOSAGE & ADMINISTRATION

Dosage must be individualized according to the patient’s diagnosis, age, body weight or body surface area, clinical response, IGF-1 levels, and tolerability.

General Administration Guidance:
• Administer by subcutaneous injection only, unless otherwise directed by the official product label.
• Common injection sites include the abdomen, thigh, buttock, or upper arm.
• Rotate injection sites regularly to reduce the risk of local tissue changes.
• Do not use if the solution appears cloudy, discolored, or contains particles after preparation.
• Patients or caregivers should receive proper training before home administration.
• Do not share needles, syringes, pens, or vials.

This section is for medical catalog reference only and is not a substitute for a prescriber’s dosing instructions.

MECHANISM OF ACTION

Somatropin binds to growth hormone receptors on target tissues, triggering intracellular signaling pathways that support the production of growth hormone–dependent proteins, including IGF-1. Through direct and IGF-1-mediated effects, somatropin contributes to linear growth in pediatric patients with open growth plates and influences protein, fat, carbohydrate, and mineral metabolism.

PRECAUTIONS

Use somatropin with caution and only under medical supervision in patients with:

• Diabetes mellitus or impaired glucose tolerance
• History of malignancy or intracranial tumor
• Thyroid or adrenal hormone disorders
• Scoliosis or rapid growth-related orthopedic concerns
• History of pancreatitis or unexplained severe abdominal pain
• Prader-Willi syndrome with severe obesity, sleep apnea, or respiratory impairment
• Pregnancy, planned pregnancy, or breastfeeding, unless clearly advised by a physician

Somatropin is generally contraindicated in patients with active malignancy, acute critical illness, severe diabetic retinopathy, hypersensitivity to somatropin or excipients, and pediatric patients with closed epiphyses when used for growth promotion.

POSSIBLE SIDE EFFECTS

Common or clinically reported side effects may include:

• Injection-site redness, pain, swelling, itching, or skin thickening
• Headache
• Muscle or joint pain
• Fluid retention, swelling, or tingling sensations
• Cold or flu-like symptoms
• Ear discomfort or respiratory symptoms
• Changes in blood glucose levels

Serious adverse effects may include severe allergic reaction, visual changes with headache or nausea, intracranial hypertension, worsening glucose intolerance, pancreatitis, progression or recurrence of malignancy, slipped capital femoral epiphysis in pediatric patients, and breathing problems in high-risk patients.

Patients should seek medical attention for severe headache, vision changes, allergic reactions, persistent abdominal pain, new limping, breathing difficulty, or unusual swelling.

STORAGE

Store according to the official manufacturer’s label and pharmacist instructions.

General somatropin storage guidance:
• Store refrigerated at 2°C to 8°C unless the product label states otherwise.
• Do not freeze.
• Protect from direct light.
• Keep out of reach of children.
• After reconstitution or first use, follow the manufacturer’s specified beyond-use period.
• Discard any product that has been frozen, improperly stored, expired, cloudy, discolored, or contaminated.